Cargando…
Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action
BACKGROUND: The marketing of unproven direct-to-consumer stem cell interventions is becoming widespread in Canada. There is little evidence supporting their use and they have been associated with a range of harms. Canada has been slower to act against clinics offering these interventions than other...
Autores principales: | Caulfield, Timothy, Murdoch, Blake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683337/ https://www.ncbi.nlm.nih.gov/pubmed/31383026 http://dx.doi.org/10.1186/s12910-019-0388-4 |
Ejemplares similares
-
Unproven stem cell–based interventions and achieving a compromise policy among the multiple stakeholders
por: Matthews, Kirstin R. W., et al.
Publicado: (2015) -
Endometrial Receptivity Analysis (ERA) test: an unproven
technology
por: Ben Rafael, Zion
Publicado: (2021) -
Dangerous medicines: Unproven AIDS cures and counterfeit antiretroviral drugs
por: Amon, Joseph J
Publicado: (2008) -
Policy recommendations for addressing privacy challenges associated with cell-based research and interventions
por: Ogbogu, Ubaka, et al.
Publicado: (2014) -
The law and problematic marketing by private umbilical cord blood banks
por: Murdoch, Blake, et al.
Publicado: (2020)